FR2015053A1 - - Google Patents

Info

Publication number
FR2015053A1
FR2015053A1 FR6925823A FR6925823A FR2015053A1 FR 2015053 A1 FR2015053 A1 FR 2015053A1 FR 6925823 A FR6925823 A FR 6925823A FR 6925823 A FR6925823 A FR 6925823A FR 2015053 A1 FR2015053 A1 FR 2015053A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6925823A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2015053A1 publication Critical patent/FR2015053A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6925823A 1968-08-05 1969-07-29 Withdrawn FR2015053A1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1170468 1968-08-05

Publications (1)

Publication Number Publication Date
FR2015053A1 true FR2015053A1 (cg-RX-API-DMAC10.html) 1970-04-24

Family

ID=4376070

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6925823A Withdrawn FR2015053A1 (cg-RX-API-DMAC10.html) 1968-08-05 1969-07-29

Country Status (23)

Country Link
US (2) US3594474A (cg-RX-API-DMAC10.html)
AT (1) AT290731B (cg-RX-API-DMAC10.html)
BE (1) BE737053A (cg-RX-API-DMAC10.html)
BG (1) BG17466A3 (cg-RX-API-DMAC10.html)
BR (1) BR6911321D0 (cg-RX-API-DMAC10.html)
CA (1) CA938889A (cg-RX-API-DMAC10.html)
CY (1) CY790A (cg-RX-API-DMAC10.html)
DE (1) DE1938108C3 (cg-RX-API-DMAC10.html)
DK (1) DK123912B (cg-RX-API-DMAC10.html)
FI (1) FI50058C (cg-RX-API-DMAC10.html)
FR (1) FR2015053A1 (cg-RX-API-DMAC10.html)
GB (1) GB1259387A (cg-RX-API-DMAC10.html)
IE (1) IE33246B1 (cg-RX-API-DMAC10.html)
IL (1) IL32673A (cg-RX-API-DMAC10.html)
IT (1) IT1035508B (cg-RX-API-DMAC10.html)
MY (1) MY7500079A (cg-RX-API-DMAC10.html)
NL (1) NL162837C (cg-RX-API-DMAC10.html)
NO (1) NO129183B (cg-RX-API-DMAC10.html)
OA (1) OA03604A (cg-RX-API-DMAC10.html)
PL (1) PL88871B1 (cg-RX-API-DMAC10.html)
RO (1) RO57881A (cg-RX-API-DMAC10.html)
SE (1) SE363735B (cg-RX-API-DMAC10.html)
SU (1) SU409407A3 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
DE3773926D1 (de) * 1987-07-22 1991-11-21 Farvalsa Ag Feuchtigkeitsstabile feste valproinsaeure-zubereitung und verfahren zu ihrer herstellung.

Also Published As

Publication number Publication date
NO129183B (cg-RX-API-DMAC10.html) 1974-03-11
AT290731B (de) 1971-06-11
CY790A (en) 1976-06-01
FI50058C (fi) 1975-12-10
IT1035508B (it) 1979-10-20
US3655870A (en) 1972-04-11
SU409407A3 (cg-RX-API-DMAC10.html) 1973-11-30
SE363735B (cg-RX-API-DMAC10.html) 1974-02-04
DE1938108A1 (de) 1970-02-26
FI50058B (cg-RX-API-DMAC10.html) 1975-09-01
DK123912B (da) 1972-08-21
CA938889A (en) 1973-12-25
BE737053A (cg-RX-API-DMAC10.html) 1970-02-04
RO57881A (cg-RX-API-DMAC10.html) 1974-11-15
NL6911864A (cg-RX-API-DMAC10.html) 1970-02-09
GB1259387A (cg-RX-API-DMAC10.html) 1972-01-05
IE33246L (en) 1970-02-05
US3594474A (en) 1971-07-20
MY7500079A (en) 1975-12-31
IE33246B1 (en) 1974-05-01
DE1938108C3 (de) 1974-01-03
IL32673A0 (en) 1969-09-25
BR6911321D0 (pt) 1973-02-13
BG17466A3 (bg) 1973-11-10
NL162837C (nl) 1980-07-15
NL162837B (nl) 1980-02-15
OA03604A (fr) 1971-03-30
IL32673A (en) 1973-11-28
PL88871B1 (cg-RX-API-DMAC10.html) 1976-10-30

Similar Documents

Publication Publication Date Title
AU5506869A (cg-RX-API-DMAC10.html)
AU5184069A (cg-RX-API-DMAC10.html)
AU6168869A (cg-RX-API-DMAC10.html)
SU409407A3 (cg-RX-API-DMAC10.html)
AU2952567A (cg-RX-API-DMAC10.html)
AU4811568A (cg-RX-API-DMAC10.html)
AU421558B1 (cg-RX-API-DMAC10.html)
AU4744468A (cg-RX-API-DMAC10.html)
AU3789668A (cg-RX-API-DMAC10.html)
AU2580267A (cg-RX-API-DMAC10.html)
AU3224368A (cg-RX-API-DMAC10.html)
AR203075Q (cg-RX-API-DMAC10.html)
BE709095A (cg-RX-API-DMAC10.html)
BE724687A (cg-RX-API-DMAC10.html)
BE642636A (cg-RX-API-DMAC10.html)
AU4464266A (cg-RX-API-DMAC10.html)
BE709484A (cg-RX-API-DMAC10.html)
AU2496167A (cg-RX-API-DMAC10.html)
BE728311A (cg-RX-API-DMAC10.html)
BE725673A (cg-RX-API-DMAC10.html)
BE727324A (cg-RX-API-DMAC10.html)
BE709274A (cg-RX-API-DMAC10.html)
AU4558658A (cg-RX-API-DMAC10.html)
BE581157A (cg-RX-API-DMAC10.html)
BE709496A (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse